Editorial
doi: 10.1126/sciimmunol.abb8618.
Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2?
Affiliations
- PMID: 32245885
- DOI: 10.1126/sciimmunol.abb8618
Item in Clipboard
Editorial
Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2?
Sci Immunol.
.
Abstract
Many strategies are being deployed to rapidly uncover targetable mechanisms of infection for SARS-CoV-2, and Hoffman et al exploit our understanding and immunological experience with SARS-CoV in our global race to understand, mitigate, and eventually prevent COVID-19.
Copyright © 2020, American Association for the Advancement of Science.
Similar articles
-
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5. Cell. 2020. PMID: 32142651 Free PMC article.
-
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.Viruses. 2020 Jun 10;12(6):629. doi: 10.3390/v12060629. Viruses. 2020. PMID: 32532094 Free PMC article.
-
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.Future Oncol. 2020 Sep;16(27):2029-2033. doi: 10.2217/fon-2020-0571. Epub 2020 Jul 13. Future Oncol. 2020. PMID: 32658591 Free PMC article. No abstract available.
-
TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?Cancer Discov. 2020 Jun;10(6):779-782. doi: 10.1158/2159-8290.CD-20-0451. Epub 2020 Apr 10. Cancer Discov. 2020. PMID: 32276929 Free PMC article. Review.
-
Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Hum Vaccin Immunother. 2020 Oct 2;16(10):2366-2369. doi: 10.1080/21645515.2020.1787064. Epub 2020 Sep 22. Hum Vaccin Immunother. 2020. PMID: 32961082 Free PMC article. Review.
Cited by
-
Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases.Methods Mol Biol. 2022;2410:229-263. doi: 10.1007/978-1-0716-1884-4_11. Methods Mol Biol. 2022. PMID: 34914050
-
Harnessing immunological targets for COVID-19 immunotherapy.Future Virol. 2021 Jul:10.2217/fvl-2021-0048. doi: 10.2217/fvl-2021-0048. Epub 2021 Aug 9. Future Virol. 2021. PMID: 34447458 Free PMC article. Review.
-
Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era.Front Immunol. 2021 Jul 8;12:683440. doi: 10.3389/fimmu.2021.683440. eCollection 2021. Front Immunol. 2021. PMID: 34305916 Free PMC article. Review.
-
BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?Front Pharmacol. 2020 Jul 9;11:1050. doi: 10.3389/fphar.2020.01050. eCollection 2020. Front Pharmacol. 2020. PMID: 32754036 Free PMC article. Review.
-
The complement system in COVID-19: friend and foe?JCI Insight. 2020 Aug 6;5(15):e140711. doi: 10.1172/jci.insight.140711. JCI Insight. 2020. PMID: 32554923 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
